On September 24, 2012, QLT Inc. announced that it completed the sale of the Company's Visudyne® business to Valeant Pharmaceuticals International, Inc.
For more information on Visudyne, please refer to the Visudyne Web site.
Visudyne® is a registered trademark of Novartis AG
HEAD OFFICE: QLT Inc. 887 Great Northern Way, Suite 101, Vancouver, BC, Canada, V5T 4T5 | t 877.764.3131
